Colgate Oral Health Network

THIS ASK THE EXPERT AREA IS CLOSED
We are no longer receiving questions or comments for this content. Please see below for previous interaction, as your comment may already be addressed.

"Responsibilities and Requirements of Prescribing Schedule II Opioid Drugs" has been planned and implemented in accordance with the standards of the AGD Pace and is supported by funds received from Colgate Oral Pharmaceuticals Inc. Tribune Group GmbH is a recognized AGD Pace provider. At the end of the webinar, after passing the C.E. Quiz, you will be able to download your AGD Pace C.E. Certificate.

OTHER WEBINARS YOU MAY BE INTERESTED IN

Partner: Santa Fe Group

On-demand webinar

The Strengths and Weaknesses of Publicly Supported Dental Benefits Programs within the U.S.
Elisa Chavez

Dr. Elisa Chavez D.D.S.

Nader Nadershahi

Dr. Nader Nadershahi D.D.S., M.B.A, Ed.D.

Nicholas G.  Mosca

Dr. Nicholas G. Mosca DDS, DrPH

The Strengths and Weaknesses of Publicly Supported Dental Benefits Programs within the U.S.

On-demand webinar

Financial Statement Analysis for the Emerging Dentist
Cameron Shahbazian

Dr. Cameron Shahbazian DMD MBA FICD FACD, Clinical Associate Professor Boston University Henry M Goldman School of Dental Medicine

Financial Statement Analysis for the Emerging Dentist

On-demand webinar

Increasing Patient Engagement:
Efficacy of Educational Interventions
Ann Eshenaur Spolarich

Ann Eshenaur Spolarich RDH, PhD, FSCDH, Professor and Assistant Dean for Research, Arizona School of Dentistry & Oral Health, A.T. Still University

Increasing Patient Engagement: Efficacy of Educational Interventions